"10.1371_journal.pone.0070626","plos one","2013-08-12T00:00:00Z","Katja Derkow; Jakob M J Bauer; Michael Hecker; Brigitte K Paap; Madhan Thamilarasan; Dirk Koczan; Eckart Schott; Katrin Deuschle; Judith Bellmann-Strobl; Friedemann Paul; Uwe K Zettl; Klemens Ruprecht; Seija Lehnardt","Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Department of Neurology, University of Rostock, Rostock, Germany; Institute of Immunology, University of Rostock, Rostock, Germany; Department of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Clinical and Experimental Multiple Sclerosis Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany; Cluster of Excellence NeuroCure, Charité - Universitätsmedizin Berlin, Berlin, Germany; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin and Max-Delbrück Center for Molecular Medicine, Berlin, Germany; Institute of Cell Biology and Neurobiology, Center for Anatomy, Charité - Universitätsmedizin Berlin, Berlin, Germany","¶ These authors also contributed equally to this work.","MH received speaking fees from Bayer HealthCare and Novartis. FP received research support as well as speaking fees and travel grants from Bayer HealthCare, Biogen Idec, Merck Serono, Sanofi-Aventis, and Novartis. UKZ received research support as well as speaking fees from Bayer HealthCare, Biogen Idec, Merck Serono, Novartis, Sanofi-Aventis, Teva, and Almirall. The Affymetrix microarray experiments were funded by Bayer HealthCare (to UKZ). KR received research support from Novartis as well as speaking fees and travel grants from Bayer HealthCare, Biogen Idec, Merck Serono, Sanofi-Aventis, and Novartis. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","08","Katja Derkow","KD",13,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
